Viewing Study NCT04458051


Ignite Creation Date: 2025-12-24 @ 11:52 PM
Ignite Modification Date: 2026-02-11 @ 3:21 PM
Study NCT ID: NCT04458051
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-08-17
First Post: 2020-07-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)
Sponsor: Sanofi
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Primary Progressive Multiple Sclerosis View
Keywords: